Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Send an inquiry form See our COA process Research applications Skin- and extracellular-matrix research models Copper-peptide (GHK-Cu) signalling research Angiogenesis and cytoprotection research Multi-peptide comparative research models Listed for research context only Certiva makes no medical, therapeutic, or dosing claims
GHK-Cus biphasic MMP regulation breaks down disorganized scar collagen while stimulating new, properly organized collagen formation
A 150lb individual and a 250lb individual should not use identical doses and expect equivalent results
So, envisioning a way ahead, to summarize: BPC-157 may be beneficial in healing orthopaedic injuries and once it is approved for human therapeutic use by any governmental regulatory health authority (FDA is just one of many) it would not be a non-approved substance under class S-0 of the WADA Code, and therefore not be banned
